2012 jdrf hope ball invitation

Committee ChairsDana Germer

Cristi Trusler

JDRF Executive TeamVicki Callegari

Executive Director

Kari Rouse

Special Events Manager

Amy Hyman

Development Manager

Melissa Ray

Office Manager & Volunteer Coordinator

Tristina Oppliger

Special Events Assistant

2012 Hope Ball HonoreesPast JDRF Austin Board Presidents

Past Honorees2002 Debbie & Kevin Rollins

2003 Liz & Kirk Watson

2004 Marnie & Dave Near

2005 Papermaster Family

2006 Rachel & John Schuler

2007 Laura & Todd Templeton

2008 Austin mothers of children with type 1

Mary Cantrell, Laura Crumpacker, Cindy Goldrick,

Cindy Salinas, Melissa Segrest, Nancy Stobaugh

and Jodi Zipp

2009 Isabelle Carpenter, her brother Walker and parents

Art and Alexandra Carpenter

2010 Walt Thirion

2011 Toni & Tim Clark

JDRF Board of DirectorsJosh Alsup

Christos Anagnos

Gene Austin

Greg Bailes

Terry Browne

Darryl Crawford

Tracey Davies

Steve Dean

Becca Dietz

Mark Garrett

Tom Gentry

Betty Hewell

Beckie McCleery

Jeff Needles

Morgan Stone

David Robshaw

Ronnie Taylor

Laura Templeton

Sharlyn Threadgill

Dave Waller, President

Mike Walker

Todd Werner

Valerie Wheelock, M.D.

Rachel Wyatt

3420 Executive Center DriveSuite 108

Austin, Texas 78731Phone: 512.343.0663

Fax: 512.343.0773www.jdrf.org/austin

M a y a d i a g n o s e d a t a g e 3

M o r g a n d i a g n o s e d a t a g e 1 2

JDRF Research Funding Overview• Since its founding in 1970, JDRF has funded more than $1.6 billion in T1D research and has dramatically advanced

the T1D scientific frontier and the management of this disease. In FY2011 alone, JDRF provided more than $116

million for T1D research.

• More than 80 percent of JDRF’s expenditures directly support research and research-related education.

JDRF maintains one of the best records among all non-profits for effective and efficient management of donor

contributions.

• In FY2011, JDRF funded research projects in 18 countries representing the global scope of JDRF’s research efforts.

• As more JDRF programs move forward, the number of human or clinical studies has grown. In FY2011, JDRF

supported 53 clinical studies, including evaluations of new therapies, studies of the normal course of T1D, and

others to collect specific T1D human samples.

J D R F ’ s R e s e a R c h G o a l sJDRF research is committed to improving the lives of every person with T1D and to curing this disease.

JDRF’s research goals are realized by the projects being supported in three basic areas:

c u R eRestoring a person’s insulin-producing capability and halting or reversing the body’s misguided immune attack on

the pancreas.

t R e a tDeveloping new devices and therapies that optimize blood sugar control and treat or prevent the complications

of T1D.

p R e v e n tPreventing T1D from occurring or stopping the disease process before it damages the pancreas.

Photography by Rala Imaging

D e d i c a t e d t o D e l i v e r i n g t h e

Message of Hope a n d a c u r e f o r t y p e 1 d i a b e t e s

Type 1 diabetes is an autoimmune disease which strikes in childhood, adolescence, or adulthood, but lasts a lifetime. As many as 3 million Americans have type 1 diabetes. Approximately 80 people every day are diagnosed with type 1 diabetes in the U.S.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF is the world’s leading funder and advocate of type 1 diabetes science.

K i l e y d i a g n o s e d a t a g e 8

L u k e d i a g n o s e d a t a g e 7

J D R F J D R F J D R F J D R F J D R F J D R F J D R F J D R F J D R F J D R F



2012 Hope Ball A10 Invitation.indd 1-3 3/26/12 2:43 PM

Saturday, May 12, 2012

Evening Highlights6:00 p.m.Cocktail Reception

Silent Auction

8:00 p.m. Ballroom Doors Open

Dinner Served

Silent Auction Closes

9:00 p.m. Fund A Cure

Live Auction

10:00 p.m.Dessert Bar

Entertainment by

The Spazmatics

6:00 p.m.

Renaissance Austin Hotel9721 Arboretum Blvd.

Austin, TX 78759

Black Tie Optional

Honoreescelebrating the service and commitment of our past JDRF austin Board presidents

Mark Garrett 2010-11

Toni Clark 2008-10

Zoltan Papp 2006-08

Christos Anagnos 2004-06

James Erben 2002-04

Jim Brown 2000-02

Gail Papermaster 1998-2000

1 3 t h a n n u a l h o p e B a l l benefiting JDRF

W i l l S . d i a g n o s e d a t 8 m o . o l d

S y d n e y d i a g n o s e d a t a g e 2 ( l e f t )

A u d r e y d i a g n o s e d a t a g e 3 ( r i g h t )

S a r a d i a g n o s e d a t a g e 2 7 & h e r s o n J a c k

W i l l L . d i a g n o s e d a t a g e 8

A n d r e a d i a g n o s e d a t a g e 2 7

hope for a cure from type 1 diabetes blooms only with your support.

R.S.V.P. To reserve your table, please complete the enclosed reply card or purchase tickets online at www.jdrf.org/austin

For more information, please call 512.343.0663




H o p e B l o o m s — i m p r o v i n g l i v e s , c u r i n g t y p e 1 d i a b e t e s w i t h y o u r s u p p o r t .P a r k e r d i a g n o s e d a t a g e 4

Fund A CureG i v i n g H o p e — A d v a n c i n g C u r e T h e r a p i e sAt the JDRF Austin Hope Ball on May 12, 2012, there will be a moment after

Live Auction when the room will be stilled and the story of hope will unfold; we call

this special time “Fund A Cure.” During Fund A Cure, you will have the opportunity

to donate directly to research and fund the science that will transform the lives of

our friends and families living with type 1 diabetes.

This year all proceeds from Fund A Cure will support the important work being done

in the area of Cure Therapies. Such important research in this arena of JDRF research

is dedicated to replacing or regenerating beta cells, and halting the autoimmune

process. Critical progress is currently being made in the following areas: Beta Cell

Regeneration, Health and Survival, Encapsulation/Immunoisolation of Alternative

Beta Cell Sources, Antigen-specific Immunotherapies and Vaccines and Biomarkers:

Staging, Prognostic, and Predictive.

Last year JDRF directed $57.3 million to researchers working in this important

arena. Your support of the Cure Therapies Program through Fund A Cure is

100% tax-deductible and will enable us to pursue our mission to find a cure

for type 1 and its complications through the support of research.

Our MissiOnthe mission of JDRF

is to find a cure for

type 1 diabetes and its

complications through the

support of research. K e l l y d i a g n o s e d a t a g e 1 5 & s o n

N o a h d i a g n o s e d a t 2 0 m o n t h s

M i a d i a g n o s e d a t a g e 2


Committee ChairsDana Germer

Cristi Trusler

JDRF Executive TeamVicki Callegari

Executive Director

Kari Rouse

Special Events Manager

Amy Hyman

Development Manager

Melissa Ray

Office Manager & Volunteer Coordinator

Tristina Oppliger

Special Events Assistant

2012 Hope Ball HonoreesPast JDRF Austin Board Presidents

Past Honorees2002 Debbie & Kevin Rollins

2003 Liz & Kirk Watson

2004 Marnie & Dave Near

2005 Papermaster Family

2006 Rachel & John Schuler

2007 Laura & Todd Templeton

2008 Austin mothers of children with type 1

Mary Cantrell, Laura Crumpacker, Cindy Goldrick,

Cindy Salinas, Melissa Segrest, Nancy Stobaugh

and Jodi Zipp

2009 Isabelle Carpenter, her brother Walker and parents

Art and Alexandra Carpenter

2010 Walt Thirion

2011 Toni & Tim Clark

JDRF Board of DirectorsJosh Alsup

Christos Anagnos

Gene Austin

Greg Bailes

Terry Browne

Darryl Crawford

Tracey Davies

Steve Dean

Becca Dietz

Mark Garrett

Tom Gentry

Betty Hewell

Beckie McCleery

Jeff Needles

Morgan Stone

David Robshaw

Ronnie Taylor

Laura Templeton

Sharlyn Threadgill

Dave Waller, President

Mike Walker

Todd Werner

Valerie Wheelock, M.D.

Rachel Wyatt

3420 Executive Center DriveSuite 108

Austin, Texas 78731Phone: 512.343.0663

Fax: 512.343.0773www.jdrf.org/austin

M a y a d i a g n o s e d a t a g e 3

M o r g a n d i a g n o s e d a t a g e 1 2

JDRF Research Funding Overview• Since its founding in 1970, JDRF has funded more than $1.6 billion in T1D research and has dramatically advanced

the T1D scientific frontier and the management of this disease. In FY2011 alone, JDRF provided more than $116

million for T1D research.

• More than 80 percent of JDRF’s expenditures directly support research and research-related education.

JDRF maintains one of the best records among all non-profits for effective and efficient management of donor

contributions.

• In FY2011, JDRF funded research projects in 18 countries representing the global scope of JDRF’s research efforts.

• As more JDRF programs move forward, the number of human or clinical studies has grown. In FY2011, JDRF

supported 53 clinical studies, including evaluations of new therapies, studies of the normal course of T1D, and

others to collect specific T1D human samples.

J D R F ’ s R e s e a R c h G o a l sJDRF research is committed to improving the lives of every person with T1D and to curing this disease.

JDRF’s research goals are realized by the projects being supported in three basic areas:

c u R eRestoring a person’s insulin-producing capability and halting or reversing the body’s misguided immune attack on

the pancreas.

t R e a tDeveloping new devices and therapies that optimize blood sugar control and treat or prevent the complications

of T1D.

p R e v e n tPreventing T1D from occurring or stopping the disease process before it damages the pancreas.

Photography by Rala Imaging

D e d i c a t e d t o D e l i v e r i n g t h e

Message of Hope a n d a c u r e f o r t y p e 1 d i a b e t e s

Type 1 diabetes is an autoimmune disease which strikes in childhood, adolescence, or adulthood, but lasts a lifetime. As many as 3 million Americans have type 1 diabetes. Approximately 80 people every day are diagnosed with type 1 diabetes in the U.S.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF is the world’s leading funder and advocate of type 1 diabetes science.

K i l e y d i a g n o s e d a t a g e 8

L u k e d i a g n o s e d a t a g e 7





2012 jdrf hope ball invitation

Documents

t e d t o d e

b e t e stype

j d r f s r e s e

g n o s e d

e r i n g t h e message

t1d research

p r e v e n tpreventing

c u r e f o r t y p